NRG
BME icon

Nemes Rush Group’s BlackRock Health Sciences Trust BME Stock Holding History

Nemes Rush Group’s Portfolio BME Stock Details BME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-939
Closed -$36.3K – 726
2025
Q1 		$36.3K Buy
939
+18
+2% +$714 ﹤0.01% 353
2024
Q4 		$34.9K Buy
921
+21
+2% +$838 ﹤0.01% 343
2024
Q3 		$37.3K Hold
900
– – 0.01% 292
2024
Q2 		$36.8K Hold
900
– – 0.01% 289
2024
Q1 		$37.3K Hold
900
– – 0.01% 316
2023
Q4 		$36.4K Hold
900
– – 0.01% 296
2023
Q3 		$35.2K Hold
900
– – 0.01% 290
2023
Q2 		$36.6K Buy
+900
New +$37K 0.01% 302

Other funds holding BME

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
NRW
Nova R Wealth Overland Park, Kansas $343M AUM 17.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CA
Cornerstone Advisory Hunt Valley, Maryland $1.06B AUM 12.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Nemes Rush Group's BME Position: Q2 2025 in Review

Nemes Rush Group sold out of BlackRock Health Sciences Trust (BME) in Q2 2025, closing a stake of 939 shares — an estimated $36.3K sold.

Nemes Rush Group first reported a position in BME in Q2 2023 and held it in 8 quarters. The position peaked at $37.3K in Q3 2024. 72 funds tracked by Wall St. Rank hold BME as of Q2 2025.

  • Nemes Rush Group reported no remaining BlackRock Health Sciences Trust position as of Q2 2025 after selling out during the quarter.
  • Nemes Rush Group sold 939 BlackRock Health Sciences Trust shares in Q2 2025, an estimated $36.3K.
  • Nemes Rush Group first reported a position in BlackRock Health Sciences Trust in Q2 2023 and held it in 8 quarters.
  • Nemes Rush Group's BlackRock Health Sciences Trust position peaked at $37.3K in Q3 2024.
  • 72 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2025.

Based on Nemes Rush Group's 13F filing for Q2 2025, filed 12 Aug 2025.